Endoscopic ultrasonography complements computed tomography in predicting portal or superior mesenteric vein resection in patients with borderline resectable pancreatic carcinoma

Evan Glazer, Omar M. Rashid, Jason B. Klapman, Cynthia L. Harris, Pamela J. Hodul, Jose M. Pimiento, Mokenge P. Malafa

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background Current guidelines recommend computed tomographic (CT) scans for vascular staging of patients with pancreatic carcinoma; however, endoscopic ultrasonography (EUS) in these patients is not required and its utility in combination with CT scan is less well-defined. The purpose of this study is to explore the utility of EUS in addition to CT in identifying patients with borderline resectable pancreatic carcinoma (BRPC). Methods We reviewed our database of patients with BRPC who went to surgery with curative intent. Inclusion criteria were preoperative staging with CT scan and EUS, completion of neoadjuvant chemotherapy and radiotherapy, and surgical resection. Results We identified 62 patients (average age of 65 ± 9 years, 60% male); 97% of patients underwent R0 resections. We found that 29% of patients were classified as BRPC by EUS alone, 23% by CT alone, and 48% by both modalities. Of 34 patients who required vein resection, EUS alone preoperatively identified 88% of these patients while CT alone identified 67%. EUS identified 11 patients who required vein resection that CT did not identify as BRPC, whereas CT identified 4 patients that EUS did not identify as BRPC. On multivariate analysis, EUS was associated with vein resection (P < 0.02), but CT scan findings, tumor size, and CA19-9 values were not associated (each P > 0.1). Conclusions EUS complemented CT in identifying BRPC patients requiring vein resection, with nearly one-third of patients identified with EUS alone, supporting EUS use in addition to CT scan for vascular staging of patients with pancreatic carcinoma.

Original languageEnglish (US)
Pages (from-to)130-134
Number of pages5
JournalPancreatology
Volume17
Issue number1
DOIs
StatePublished - Jan 1 2017
Externally publishedYes

Fingerprint

Mesenteric Veins
Endosonography
Tomography
Veins
Pancreatic Carcinoma
Blood Vessels

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Endocrinology

Cite this

Endoscopic ultrasonography complements computed tomography in predicting portal or superior mesenteric vein resection in patients with borderline resectable pancreatic carcinoma. / Glazer, Evan; Rashid, Omar M.; Klapman, Jason B.; Harris, Cynthia L.; Hodul, Pamela J.; Pimiento, Jose M.; Malafa, Mokenge P.

In: Pancreatology, Vol. 17, No. 1, 01.01.2017, p. 130-134.

Research output: Contribution to journalArticle

Glazer, Evan ; Rashid, Omar M. ; Klapman, Jason B. ; Harris, Cynthia L. ; Hodul, Pamela J. ; Pimiento, Jose M. ; Malafa, Mokenge P. / Endoscopic ultrasonography complements computed tomography in predicting portal or superior mesenteric vein resection in patients with borderline resectable pancreatic carcinoma. In: Pancreatology. 2017 ; Vol. 17, No. 1. pp. 130-134.
@article{38e61227033b4117a4190e3f804c9014,
title = "Endoscopic ultrasonography complements computed tomography in predicting portal or superior mesenteric vein resection in patients with borderline resectable pancreatic carcinoma",
abstract = "Background Current guidelines recommend computed tomographic (CT) scans for vascular staging of patients with pancreatic carcinoma; however, endoscopic ultrasonography (EUS) in these patients is not required and its utility in combination with CT scan is less well-defined. The purpose of this study is to explore the utility of EUS in addition to CT in identifying patients with borderline resectable pancreatic carcinoma (BRPC). Methods We reviewed our database of patients with BRPC who went to surgery with curative intent. Inclusion criteria were preoperative staging with CT scan and EUS, completion of neoadjuvant chemotherapy and radiotherapy, and surgical resection. Results We identified 62 patients (average age of 65 ± 9 years, 60{\%} male); 97{\%} of patients underwent R0 resections. We found that 29{\%} of patients were classified as BRPC by EUS alone, 23{\%} by CT alone, and 48{\%} by both modalities. Of 34 patients who required vein resection, EUS alone preoperatively identified 88{\%} of these patients while CT alone identified 67{\%}. EUS identified 11 patients who required vein resection that CT did not identify as BRPC, whereas CT identified 4 patients that EUS did not identify as BRPC. On multivariate analysis, EUS was associated with vein resection (P < 0.02), but CT scan findings, tumor size, and CA19-9 values were not associated (each P > 0.1). Conclusions EUS complemented CT in identifying BRPC patients requiring vein resection, with nearly one-third of patients identified with EUS alone, supporting EUS use in addition to CT scan for vascular staging of patients with pancreatic carcinoma.",
author = "Evan Glazer and Rashid, {Omar M.} and Klapman, {Jason B.} and Harris, {Cynthia L.} and Hodul, {Pamela J.} and Pimiento, {Jose M.} and Malafa, {Mokenge P.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/j.pan.2016.12.001",
language = "English (US)",
volume = "17",
pages = "130--134",
journal = "Pancreatology",
issn = "1424-3903",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Endoscopic ultrasonography complements computed tomography in predicting portal or superior mesenteric vein resection in patients with borderline resectable pancreatic carcinoma

AU - Glazer, Evan

AU - Rashid, Omar M.

AU - Klapman, Jason B.

AU - Harris, Cynthia L.

AU - Hodul, Pamela J.

AU - Pimiento, Jose M.

AU - Malafa, Mokenge P.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Background Current guidelines recommend computed tomographic (CT) scans for vascular staging of patients with pancreatic carcinoma; however, endoscopic ultrasonography (EUS) in these patients is not required and its utility in combination with CT scan is less well-defined. The purpose of this study is to explore the utility of EUS in addition to CT in identifying patients with borderline resectable pancreatic carcinoma (BRPC). Methods We reviewed our database of patients with BRPC who went to surgery with curative intent. Inclusion criteria were preoperative staging with CT scan and EUS, completion of neoadjuvant chemotherapy and radiotherapy, and surgical resection. Results We identified 62 patients (average age of 65 ± 9 years, 60% male); 97% of patients underwent R0 resections. We found that 29% of patients were classified as BRPC by EUS alone, 23% by CT alone, and 48% by both modalities. Of 34 patients who required vein resection, EUS alone preoperatively identified 88% of these patients while CT alone identified 67%. EUS identified 11 patients who required vein resection that CT did not identify as BRPC, whereas CT identified 4 patients that EUS did not identify as BRPC. On multivariate analysis, EUS was associated with vein resection (P < 0.02), but CT scan findings, tumor size, and CA19-9 values were not associated (each P > 0.1). Conclusions EUS complemented CT in identifying BRPC patients requiring vein resection, with nearly one-third of patients identified with EUS alone, supporting EUS use in addition to CT scan for vascular staging of patients with pancreatic carcinoma.

AB - Background Current guidelines recommend computed tomographic (CT) scans for vascular staging of patients with pancreatic carcinoma; however, endoscopic ultrasonography (EUS) in these patients is not required and its utility in combination with CT scan is less well-defined. The purpose of this study is to explore the utility of EUS in addition to CT in identifying patients with borderline resectable pancreatic carcinoma (BRPC). Methods We reviewed our database of patients with BRPC who went to surgery with curative intent. Inclusion criteria were preoperative staging with CT scan and EUS, completion of neoadjuvant chemotherapy and radiotherapy, and surgical resection. Results We identified 62 patients (average age of 65 ± 9 years, 60% male); 97% of patients underwent R0 resections. We found that 29% of patients were classified as BRPC by EUS alone, 23% by CT alone, and 48% by both modalities. Of 34 patients who required vein resection, EUS alone preoperatively identified 88% of these patients while CT alone identified 67%. EUS identified 11 patients who required vein resection that CT did not identify as BRPC, whereas CT identified 4 patients that EUS did not identify as BRPC. On multivariate analysis, EUS was associated with vein resection (P < 0.02), but CT scan findings, tumor size, and CA19-9 values were not associated (each P > 0.1). Conclusions EUS complemented CT in identifying BRPC patients requiring vein resection, with nearly one-third of patients identified with EUS alone, supporting EUS use in addition to CT scan for vascular staging of patients with pancreatic carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=85009495410&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009495410&partnerID=8YFLogxK

U2 - 10.1016/j.pan.2016.12.001

DO - 10.1016/j.pan.2016.12.001

M3 - Article

VL - 17

SP - 130

EP - 134

JO - Pancreatology

JF - Pancreatology

SN - 1424-3903

IS - 1

ER -